Written By: Ben Adams, Senior Editor, FierceBiotech Life science venture capital firm Rapha Capital Management has launched its first managed venture capital fund with a target raise of $100M and...
- Rapha Capital BioVentures (RCBV) Fund, with a target of $100M, builds on Rapha Capital’s successful history guiding the advancements of target biotech investments - - RCBV Fund plans to...
Rapha Capital Management (RCM LLC) Joined by Mendham Investment Group (MIG FZ LLC) in Leading the Financing FIZE's Novel iUO™ Device Conquers the Last Frontier in Patient Monitoring Rapha Capital's...